Cite
HARVARD Citation
Cunningham, D. et al. (n.d.). 1567Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48. Open forum infectious diseases. p. S417. [Online].